I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 5% | |
| CD4-positive, alpha-beta T cell | 4 studies | 23% ± 7% | |
| neuron | 4 studies | 24% ± 9% | |
| GABAergic neuron | 4 studies | 31% ± 8% | |
| non-classical monocyte | 3 studies | 28% ± 9% | |
| B cell | 3 studies | 22% ± 1% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 27% ± 9% | |
| CD8-positive, alpha-beta T cell | 3 studies | 24% ± 3% | |
| classical monocyte | 3 studies | 27% ± 7% | |
| endothelial cell | 3 studies | 17% ± 0% | |
| epithelial cell | 3 studies | 26% ± 1% | |
| glutamatergic neuron | 3 studies | 46% ± 8% | |
| natural killer cell | 3 studies | 22% ± 7% |
